Skip to search formSkip to main contentSkip to account menu

CCDC83 gene

Known as: FLJ42119, coiled-coil domain containing 83, MGC34732 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract CT148: Small molecule immune-modulator icaritin: Safety, durable survival and inflammation-immune biomarkers in advanced hepatocellular carcinoma
Objectives: Hepatocellular carcinoma (HCC) was characterized with high heterogeneity and immune “tolerogenic”. Despite of immune… 
2016
2016
Abstract CT148: A phase Ib study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors
Background: Combining REGO, an oral multikinase inhibitor approved for the treatment of mCRC and advanced GIST, with i.v. CTX, an… 
2012
2012
KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.
Cancer/testis (CT) antigens are considered target molecules for cancer immunotherapy. To identify novel CT antigens… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)